EMA advises clinical trial managers over impact of war in Ukraine
Clinical trials in the Ukraine could be impacted by Russia’s invasion of the country, which is why the EMA is now offering advice on how to proceed based on lessons learned during Covid-19.
by ulrich quistgaard, translated by daniel pedersen
Russia’s invasion of Ukraine has been the cause of many disruptions in the region at large, and there is now also a great chance of clinical trials being impacted, according to the European Medicines Agency (EMA).
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
.jpg&w=384&q=75)
